These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22029194)

  • 41. Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study).
    Fertin M; Hennache B; Hamon M; Ennezat PV; Biausque F; Elkohen M; Nugue O; Tricot O; Lamblin N; Pinet F; Bauters C
    Am J Cardiol; 2010 Nov; 106(10):1410-6. PubMed ID: 21059429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prognostic value of point of care B-type natriuretic peptide testing and GRACE score in patients with acute coronary syndrome].
    Sun YH; Wang GL; Fu YY; Xue C; Hu DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Aug; 37(8):716-20. PubMed ID: 20021924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The predictive values of D-dimer for the early prognosis of the acute myocardial infarction (AMI): a review of 3134 AMI patients].
    Yang J; Li CS
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Dec; 24(12):725-9. PubMed ID: 23168200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk prediction in chest pain patients by biochemical markers including estimates of renal function.
    Eggers KM; Dellborg M; Oldgren J; Swahn E; Venge P; Lindahl B
    Int J Cardiol; 2008 Aug; 128(2):207-13. PubMed ID: 17662484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Brain natriuretic peptide and left ventricular remodeling after emergency percutaneous coronary intervention in acute myocardial infarction patients].
    Yu XY; Liu CZ; Wang JH; Sun JJ; Zhang HT; Luo HL; Huang CC; Jiang YQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Apr; 20(4):204-6. PubMed ID: 18419951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention.
    de Winter RJ; Stroobants A; Koch KT; Bax M; Schotborgh CE; Mulder KJ; Sanders GT; van Straalen JP; Fischer J; Tijssen JG; Piek JJ
    Am J Cardiol; 2004 Dec; 94(12):1481-5. PubMed ID: 15589000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
    He B; Ding S; Pu J; Liu JP; Song W; Du YP; Shen JY; Jin SX; Sun Y; Shen L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes.
    Passoni F; Morelli B; Seveso G; Lazzati L; Beria G; Del Rosso G; D'Urbano M; Cafiero F; Mariani G; De Servi S
    Ital Heart J; 2002 Jan; 3(1):28-33. PubMed ID: 11899586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of streptokinase therapy in STEMI and conventional therapy in NSTEMI patients on TIMI risk index, B-type natriuretic peptide and high-sensitive C-reactive protein.
    Kurt IH; Batur MK; Unal I
    Anadolu Kardiyol Derg; 2011 Sep; 11(6):530-5. PubMed ID: 21821500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention.
    Schoos MM; Kelbæk H; Kofoed KF; Køber L; Kløvgaard L; Helqvist S; Engstrøm T; Saunamäki K; Jørgensen E; Holmvang L; Clemmensen P
    Am J Cardiol; 2011 Jun; 107(11):1597-603. PubMed ID: 21439539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk stratification of chest pain patients in the emergency department by a nurse utilizing a point of care protocol.
    Hamilton AJ; Swales LA; Neill J; Murphy JC; Darragh KM; Rocke LG; Adgey J
    Eur J Emerg Med; 2008 Feb; 15(1):9-15. PubMed ID: 18180660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of interleukin-6 measurement in the diagnosis of acute myocardial infarction in emergency department.
    Ferroni P; Rosa A; Di Franco M; Palmirotta R; Guadagni F; Davì G; Bertazzoni G; Basili S
    Clin Chim Acta; 2007 Jun; 381(2):151-6. PubMed ID: 17408606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
    Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
    J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
    Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
    Circulation; 2005 Jul; 112(1):110-6. PubMed ID: 15983245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-term serial sampling of natriuretic peptides in patients presenting with chest pain.
    Kwan G; Isakson SR; Beede J; Clopton P; Maisel AS; Fitzgerald RL
    J Am Coll Cardiol; 2007 Mar; 49(11):1186-92. PubMed ID: 17367663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.